Molecular modeling study bioactive natural product of khellin analogues as a novel potential pharmacophore of EGFR inhibitors

References

• Seymore L. Novel anti-cancer agents in development: Exciting prospects and new challenges. Cancer Treat Rev 1999;25:301–312.
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplificai ion of the HER-2/neu oncogene. Science (Washington DC) 1987;235:177–182.
   PubMed Web of Science ®Google Scholar
• Sharma PS, Sharma R, Tyagi T. Receptor tyrosine kinase inhibitors as potent weapons in war against cancers. Curr Pharm Des 2009;15:758–776.
   PubMed Web of Science ®Google Scholar
• DiCicco-Bloom E, Deutsch PJ, Maltzman J, Zhang J, Pintar JE, Zheng J, Friedman WF et al. Autocrine expression and ontogenetic functions of the PACAP ligand/receptor system during sympathetic. Dev Biol 2000;219:197–213.
   PubMedGoogle Scholar
• Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707–712.
   PubMed Web of Science ®Google Scholar
• Scheurle D, Jahanzeb M, Aronsohn RS, Watzek L, Narayanan R. HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test. Anticancer Res 2000;20:2091–2096.
   PubMedGoogle Scholar
• Cox G, Vyberg M, Melgaard B, Askaa J, Oster A, O’Byrne KJ. Herceptest: HER2 expression and gene amplification in non-small cell lung cancer. Int J Cancer 2001;92:480–483.
   PubMed Web of Science ®Google Scholar
• Gullick WJ. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 1991;47:87–98.
   PubMed Web of Science ®Google Scholar
• Moscatello DK, Holgado-Madruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW et al. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res 1995;55:5536–5539.
   PubMed Web of Science ®Google Scholar
• Wikstrand CJ, McLendon RE, Friedman AH, Bigner DD. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res 1997;57:4130–4140.
   PubMed Web of Science ®Google Scholar
• Bridges AJ. The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases. Curr Med Chem 1999;6:825–843.
   PubMed Web of Science ®Google Scholar
• Boschelli DH. Small molecule inhibitors of receptor tyrosine kinases. Drugs Future 1999;24:515–537.
   Google Scholar
• Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990;61:203–212.
   PubMed Web of Science ®Google Scholar
• Hubbard SR, Till JH. Protein tyrosine kinase structure and function. Annu Rev Biochem 2000;69:373–398.
   PubMed Web of Science ®Google Scholar
• Dai Y, Guo Y, Frey RR, Ji Z, Curtin ML, Ahmed AA et al. Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors. J Med Chem 2005;48:6066–6083.
   PubMed Web of Science ®Google Scholar
• Dai Y, Hartandi K, Ji Z, Ahmed AA, Albert DH, Bauch JL et al. Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N’-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. J Med Chem 2007;50:1584–1597.
   PubMed Web of Science ®Google Scholar
• Lv PC, Zhou CF, Chen J, Liu PG, Wang KR, Mao WJ et al. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors. Bioorg Med Chem 2010;18:314–319.
   PubMed Web of Science ®Google Scholar
• Lv PC, Wang KR, Li QS, Chen J, Sun J, Zhu HL. Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents. Bioorg Med Chem 2010;18:1117–1123.
   PubMed Web of Science ®Google Scholar
• Engler TA, LaTessa KO, Iyengar R, Chai W, Agrios K. Stereoselective syntheses of substituted pterocarpans with anti-HIV activity, and 5-aza-/5-thia-pterocarpan and 2-aryl-2,3-dihydrobenzofuran analogues. Bioorg Med Chem 1996;4:1755–1769.
   PubMed Web of Science ®Google Scholar
• Dai JR, Hallock YF, Cardellina JH 2nd, Boyd MR. HIV-inhibitory and cytotoxic oligostilbenes from the leaves of Hopea malibato. J Nat Prod 1998;61:351–353.
   PubMed Web of Science ®Google Scholar
• Diyasena MNC, Sotheeswaran S, Surendrakumar S, Balasubramanian S, Bokel M, Kraus W. Balanocarpol, a new polyphenol from Balanocarpus zeylanicus (trimen) and Hopea jucunda (Thw.) (Dipterocarpaceae). J Chem Soc Perkin Trans 1985;1:1807–1809.
   Google Scholar
• Dean FM. (1973). In: ApSimon J, ed. The total synthesis of natural products. Vol. 1. New York: Wiley, 513.
   Google Scholar
• Carminati. Antiatherosclerotic use of khellin and khellinin. Chem Abstr 1965;63:12167.
   Google Scholar
• Bestetal. Chem Abstr 1951;45:9737.
   Google Scholar
• Al-Khalil S. The 1st Palestinian Medical and Health conference. August, 2005.
   Google Scholar
• Sakamoto M, Imaoka T, Motoyama M, Yamamoto Y, Takasu H. PCT Int. Appl. WO 94/21612, Otsuka Pharmaceutical Co., Ltd., Japan, 1994. Chem Abstr 1995;123:143655m.
   Google Scholar
• Fahmy IR, Abu-Shady H. Quart J Pharm Pharmacol 1947;20:281, 546.
   Google Scholar
• Scott VM, Pathak A, Mohn GR. Molecular and genetic basis of furocoumarins reactions. Mutat Res 1976;39:29.
   PubMed Web of Science ®Google Scholar
• Musajo L, Rodighiero G, Caporale G. [Photodynamic activity of natural coumarin derivatives]. Bull Soc Chim Biol 1954;36:1213–1224.
   PubMedGoogle Scholar
• Vermel EM, Tsetlin AL. On the antineoplastic activity of some furocoumarins. Vopr Onkol 1964;10:85–90. Chem Abstr 1965;62:4497.
   PubMedGoogle Scholar
• Fujioka T, Furumi K, Fujii H, Okabe H, Mihashi K, Nakano Y, Matsunaga H, et al. Chem Pharm Bull 1999;47:96–100.
   PubMed Web of Science ®Google Scholar
• Gammill RB, Day CE, Schurr PE. Khellin analogues. 1. General topological requirements for lipid-altering activity in furochromones. J Med Chem 1983;26:1672–1674.
   PubMed Web of Science ®Google Scholar
• Mashkovskii MD. Lekarstvennye sredstva (drugs). Vilnius 1993;1:396.
   Google Scholar
• Franchi GG, Bovalini L, Martelli P, Ferri S, Sbardellati E. High performance liquid chromatography analysis of the furanochromones khellin and visnagin in various organs of Ammi visnaga (L.) Lam. at different developmental stages. J Ethnopharmacol 1985;14:203–212.
   PubMed Web of Science ®Google Scholar
• Filler R, Kobayashi Y, Yagu-polskii LM, eds. (1993). Organofluorine compounds in medicinal chemistry and biomedical applications. Amsterdam: Elsevier.
   Google Scholar
• Nitiss JL. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochim Biophys Acta 1998;1400:63–81.
   PubMed Web of Science ®Google Scholar
• Wang JC. Cellular roles of DNA topoisomerases: A molecular perspective. Nat Rev Mol Cell Biol 2002;3:430–440.
   PubMed Web of Science ®Google Scholar
• Lehninger AL, Nelson DL, Cox MM. (1993). In principles of biochemistry. Chapter 5. New Delhi: CBS Publishers and Distributors, 113.
   Google Scholar
• Cole C, Reigan P, Gbaj A, Edwards PN, Douglas KT, Stratford IJ et al. Potential tumor-selective nitroimidazolylmethyluracil prodrug derivatives: Inhibitors of the angiogenic enzyme thymidine phosphorylase. J Med Chem 2003;46:207–209.
   PubMed Web of Science ®Google Scholar
• D’Arpa P, Liu LF. Topoisomerase-targeting antitumor drugs. Biochim Biophys Acta 1989;989:163–177.
   PubMed Web of Science ®Google Scholar
• Lansiaux A, Laine W, Baldeyrou B, Mahieu C, Wattez N, Vezin H et al. DNA topoisomerase II inhibition by peroxisomicine A(1) and its radical metabolite induces apoptotic cell death of HL-60 and HL-60/MX2 human leukemia cells. Chem Res Toxicol 2001;14:16–24.
   PubMed Web of Science ®Google Scholar
• Sundberg RJ. (1996). In: Katritzky AR, Rees CW, eds. Comprehensive heterocyclic chemistry II. Vol. 4. Oxford: Pergamon, 370–376.
   Google Scholar
• Fritz JE, Hipskind PA, Lobb KL, Nixon JA, Threlkeld PG, Gitter BD et al. Expedited discovery of second generation NK-1 antagonists: Identification of a nonbasic aryloxy substituent. Bioorg Med Chem Lett 2001;11:1643–1646.
   PubMedGoogle Scholar
• Meagher KL, Mewshaw RE, Evrard DA, Zhou P, Smith DL, Scerni R et al. Studies towards the next generation of antidepressants. Part 1: Indolylcyclohexylamines as potent serotonin reuptake inhibitors. Bioorg Med Chem Lett 2001;11:1885–1888.
   PubMed Web of Science ®Google Scholar
• Sosnovs K, Kutsenko MA. Mendeleev Commun 2000;10:238–239.
   Google Scholar
• Jeffreu JL. J Med Chem 2007;50:409–423.
   PubMedGoogle Scholar
• Masafumi K, Nariyasu M, Yoshimasa U, Koichi M, Masao K. J Nat Med 2010.
   Google Scholar
• Barker AJ, Gibson KH, Grundy W, Godfrey AA, Barlow JJ, Healy MP et al. Studies leading to the identification of ZD1839 (IRESSA): An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg Med Chem Lett 2001;11:1911–1914.
   PubMed Web of Science ®Google Scholar
• Schwesinger R, Schlemper H. Peralkylated polyaminophosphazenes – extremely strong, neutral nitrogen bases. Angew Chem (International English Edition) 1987;26:1167–1169.
   Web of Science ®Google Scholar
• Moyer JD, Barbacci EG, Iwata KK, Arnold L, Boman B, Cunningham A et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res 1997;57:4838–4848.
   PubMed Web of Science ®Google Scholar
• Acheson RM, Lines CT, Bryce MR, Dauter Z, Reynolds CR, Schmidpeter A. Synthesis and x-ray crystal structures of 2,3-dihydro-2-mercapto-2,1,3- -benzophosphodiazine-4(1H)-thione-2-sulphide derivatives. J Chem Soc Perkin Trans 1985;2:1913.
   Google Scholar
• Walter W, Fleck T, Voss J, Gerwin M. Über die Struktur der Thioamide und ihrer Derivate, XXXII1) Darstellung sowie IR- und 1H-NMR-spektroskopische Untersuchung von 2-Aminobenzamiden und -thiobenzamiden. Liebigs Ann Chem 1975;275.
   Google Scholar
• Nagarajan K, Shenoy SJ, Fritz H, Hosang O, Richter WJ. Reaction of Anthranilamide with Phosphorus Pentasulfide: Formation of 2-Mercapto-(1H)-1,3,2λ5-benzodiazaphosphorine-2,4-dithione. Helv Chim Acta 1985;68:900.
   Google Scholar
• Shinde BR, Shenoy SJ, Pai NR. Indian J Chem 1990;29B:711.
   Google Scholar
• Chen R, Wang J. Gaodeng Xuexiao Huaxue Xuebao 1992;923; Chem Abstr 1992;118:102089.
   Google Scholar
• Nilov DB, Solov’eva NP, Nikolaeva IS, Peters VV, Krylova LY, Gus’kova TA, Granik VG. Khim Farm Zh 1998;7:16.
   Google Scholar
• Nilov DB, Kadushkin AV, Kalistratov SG, Sokolova AS, Nikolaeva IS, Peters VV, Krylova LY, Granik VG. Khim Farm Zh 1992;63:9–10.
   Google Scholar
• Dozorova EN, Kadushkin AV, Bogdanova GA, Solov’eva NP, Granik VG. Khim Geterotsikl Soedin 1991;754.
   Google Scholar
• Stamos J, Sliwkowski MX, Eigenbrot C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 2002;277:46265–46272.
   PubMed Web of Science ®Google Scholar
• Raymond E, Faivre S, Armand JP. Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs 2000;60 Suppl 1:15–23; discussion 41–42.
   PubMedGoogle Scholar
• Ismail NS, Hattori M. Molecular modeling based approach, synthesis and in vitro assay to new indole inhibitors of hepatitis C NS3/4A serine protease. Bioorg Med Chem 2011;19:374–383.
   PubMedGoogle Scholar
• Girgis AS, Hosni HM, Barsoum FF. Novel synthesis of nicotinamide derivatives of cytotoxic properties. Bioorg Med Chem 2006;14:4466–4476.
   PubMed Web of Science ®Google Scholar
• Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988;48:589–601.
   PubMed Web of Science ®Google Scholar
• Grever MR, Schepartz SA, Chabner BA. The National Cancer Institute: Cancer drug discovery and development program. Semin Oncol 1992;19:622–638.
   PubMed Web of Science ®Google Scholar
• Boyd MR, Paull KD. Some practical considerations and applications. Drug Dev Res 1995;34:91–109.
   Web of Science ®Google Scholar
• Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768–780.
   PubMed Web of Science ®Google Scholar
• Elgazwy ASSH, Ismail NSM, Elzahabi HSA. A convenient synthesis and molecular modeling study of novel purine and pyrimidine derivatives as CDK2/cyclin A3 inhibitors. Bioorg Med Chem 2010;18:7639–7650.
   PubMed Web of Science ®Google Scholar